Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 12
Original Research
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,984 | Dovepress* | 6,586+ | 1,284 | 7,870 | |
| PubMed Central* | 1,398 | 317 | 1,715 | ||
| Totals | 7,984 | 1,601 | 9,585 | ||
| *Since 15 April 2020 | |||||
View citations on PubMed Central and Google Scholar